Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 - a systematic review and meta-analyses.

Fatoke B, Hui AL, Saqib M, Vashisth M, Aremu SO, Aremu DO, Aremu DB

Open source

DOI
10.1186/s12879-025-11089-w
Published
2025 May 19
Container
BMC infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12879-025-11089-w,
  title = {Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 - a systematic review and meta-analyses.},
  author = {Fatoke B and Hui AL and Saqib M and Vashisth M and Aremu SO and Aremu DO and Aremu DB},
  year = {2025},
  journal = {BMC infectious diseases},
  doi = {10.1186/s12879-025-11089-w},
  url = {https://doi.org/10.1186/s12879-025-11089-w}
}

RIS

TY  - JOUR
TI  - Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 - a systematic review and meta-analyses.
AU  - Fatoke B
AU  - Hui AL
AU  - Saqib M
AU  - Vashisth M
AU  - Aremu SO
AU  - Aremu DO
AU  - Aremu DB
PY  - 2025
JO  - BMC infectious diseases
DO  - 10.1186/s12879-025-11089-w
UR  - https://doi.org/10.1186/s12879-025-11089-w
ER  - 

APA

B, F., AL, H., M, S., M, V., SO, A., DO, A., & DB, A. (2025). Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 - a systematic review and meta-analyses.. BMC infectious diseases. https://doi.org/10.1186/s12879-025-11089-w

Source records